v3.26.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 11 — Fair Value Measurements

 

Under GAAP, our Consolidated Balance Sheets reflect a mixture of measurement methods for financial instruments. Derivative financial instruments are reported at fair value on our Consolidated Balance Sheets. Other financial instruments are reported at historical cost or amortized cost on our Consolidated Balance Sheets. The following are additional qualitative and quantitative disclosures regarding fair value measurements of our financial instruments.

 

Fair Value of Derivative Financial Instruments

 

Our derivative instruments consist of financially settled commodity swaps, futures, option contracts and fixed-price forward commodity contracts with certain counterparties. We determine the fair value of our derivative instruments using present value methods or standard option valuation models with assumptions about commodity prices based on those observed in underlying markets. We have consistently applied these valuation techniques in all periods presented and we believe we have obtained the most accurate information available for the types of derivative instruments we hold.

 

The fair values of our derivative instruments are sensitive to changes in forward pricing on natural gas, NGLs and crude oil. The derivatives at March 31, 2026 represent a net liability position of $341.8 million which reflects the present value, adjusted for counterparty credit risk, of the amount we expect to receive or pay in the future on our derivative instruments. If forward pricing on natural gas, NGLs and crude oil were to increase by 10%, the result would be a fair value reflecting a net liability of $524.1 million. If forward pricing on natural gas, NGLs and crude oil were to decrease by 10%, the result would be a fair value reflecting a net liability of $159.5 million.

 

Fair Value of Other Financial Instruments

 

Due to their cash or near-cash nature, the carrying value of other financial instruments included in working capital (i.e., cash and cash equivalents, accounts receivable, accounts payable) approximates their fair value. Debt is primarily the other financial instrument for which carrying value could vary significantly from fair value. We determined the supplemental fair value disclosures for our current and long-term debt as follows:

 

the TRGP Revolver, Commercial Paper Program and Securitization Facility are based on carrying value, which approximates fair value as their interest rates are based on prevailing market rates; and
the TRGP senior unsecured notes and the Partnership’s senior unsecured notes are based on quoted market prices derived from trades of the debt.

 

Contingent consideration liabilities related to business acquisitions are carried at fair value.
 

Fair Value Hierarchy

 

We categorize the inputs to the fair value measurements of financial assets and liabilities at each balance sheet reporting date using a three-tier fair value hierarchy that prioritizes the significant inputs used in measuring fair value:

 

Level 1 – observable inputs such as quoted prices in active markets;
Level 2 – inputs other than quoted prices in active markets that we can directly or indirectly observe to the extent that the markets are liquid for the relevant settlement periods; and
Level 3 – unobservable inputs in which little or no market data exists, therefore we must develop our own assumptions.

 

The following table shows a breakdown by fair value hierarchy category for (i) financial instruments measurements included on our Consolidated Balance Sheets at fair value and (ii) supplemental fair value disclosures for other financial instruments:

 

 

 

March 31, 2026

 

 

 

Carrying

 

 

Fair Value

 

 

 

Value

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Financial Instruments Recorded on Our
Consolidated Balance Sheets at Fair Value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets from commodity derivative contracts (1)

 

$

138.3

 

 

$

138.3

 

 

$

 

 

$

137.2

 

 

$

1.1

 

Liabilities from commodity derivative contracts (1)

 

 

480.1

 

 

 

480.1

 

 

 

 

 

 

480.0

 

 

 

0.1

 

Contingent consideration liability

 

 

7.6

 

 

 

7.6

 

 

 

 

 

 

 

 

 

7.6

 

Financial Instruments Recorded on Our
Consolidated Balance Sheets at Carrying Value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

100.1

 

 

 

100.1

 

 

 

 

 

 

 

 

 

 

TRGP Revolver and Commercial Paper Program

 

 

457.0

 

 

 

457.0

 

 

 

 

 

 

457.0

 

 

 

 

TRGP Senior unsecured notes

 

 

14,210.6

 

 

 

14,226.7

 

 

 

 

 

 

14,226.7

 

 

 

 

Partnership’s Senior unsecured notes

 

 

3,649.9

 

 

 

3,606.8

 

 

 

 

 

 

3,606.8

 

 

 

 

Securitization Facility

 

 

600.0

 

 

 

600.0

 

 

 

 

 

 

600.0

 

 

 

 

 

 

 

December 31, 2025

 

 

 

Carrying

 

 

Fair Value

 

 

 

Value

 

 

Total

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Financial Instruments Recorded on Our
Consolidated Balance Sheets at Fair Value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets from commodity derivative contracts (1)

 

$

189.3

 

 

$

189.3

 

 

$

 

 

$

189.2

 

 

$

0.1

 

Liabilities from commodity derivative contracts (1)

 

 

256.2

 

 

 

256.2

 

 

 

 

 

 

255.2

 

 

 

1.0

 

Contingent consideration liability

 

 

0.3

 

 

 

0.3

 

 

 

 

 

 

 

 

 

0.3

 

Financial Instruments Recorded on Our
Consolidated Balance Sheets at Carrying Value:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

166.1

 

 

 

166.1

 

 

 

 

 

 

 

 

 

 

TRGP Revolver and Commercial Paper Program

 

 

161.0

 

 

 

161.0

 

 

 

 

 

 

161.0

 

 

 

 

TRGP Senior unsecured notes

 

 

12,711.7

 

 

 

12,928.6

 

 

 

 

 

 

12,928.6

 

 

 

 

Partnership’s Senior unsecured notes

 

 

4,329.2

 

 

 

4,316.2

 

 

 

 

 

 

4,316.2

 

 

 

 

 

(1)
The fair value of derivative contracts in this table is presented on a different basis than the Consolidated Balance Sheets presentation as disclosed in “Note 10 – Derivative Instruments and Hedging Activities.” The above fair values reflect the total value of each derivative contract taken as a whole, whereas the Consolidated Balance Sheets presentation is based on the individual maturity dates of estimated future settlements. As such, an individual contract could have both an asset and liability position when segregated into its current and long-term portions for Consolidated Balance Sheets classification purposes.

 

Additional Information Regarding Level 3 Fair Value Measurements Included on Our Consolidated Balance Sheets

We report certain of our swaps at fair value using Level 3 inputs due to such derivative instruments not having observable market prices for substantially the full term of the derivative asset or liability. For valuations that include both observable and unobservable inputs, if the unobservable input is determined to be significant to the overall inputs, the entire valuation is categorized in Level 3. This includes derivative instruments valued using indicative price quotations whose contract length extends into unobservable periods. The fair value of these swaps was determined using a discounted cash flow valuation technique based on a commodity forward curve, which is based on observable or public data sources and extrapolated when observable prices are not available. The significant unobservable inputs used in the fair value measurements of our Level 3 derivatives were the forward natural gas pricing inputs, for which a significant portion of the derivative instruments’ term is beyond available forward pricing.

The fair value of the contingent consideration was determined using a Monte Carlo simulation model. Significant inputs used in the fair value measurement include forecasted volumes, term of the earn-out period, risk-adjusted discount rate, and volatility associated with the underlying assets. The inputs are not observable; therefore, the entire valuation of the contingent consideration is categorized in Level 3. The fair value of the contingent consideration is recorded within Other long-term liabilities on our Consolidated Balance Sheets. Subsequent changes in the fair value of this liability are included in Other income (expense) in our Consolidated Statements of Operations.

 

Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis

 

Nonfinancial assets and liabilities, such as long-lived assets, are measured at fair value on a nonrecurring basis at acquisition or whenever impairment indicators are present. For disclosures related to valuation techniques used in the Stakeholder Acquisition, see “Note 4 – Acquisitions and Joint Ventures.”

The techniques used to fair value assets and liabilities on a nonrecurring basis may produce a fair value calculation that may not be indicative or reflective of future fair values. Furthermore, while we believe our valuation techniques are appropriate and consistent with other market participants, the use of different techniques or assumptions to determine fair value of certain financial and nonfinancial assets and liabilities could result in a different fair value measurement at the reporting date.